Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in DYAI — Dyadic International Inc

CIK 72971 SAN FRANCISCO, CA
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$790
+$645 QoQ
Shares Held
878
+393.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 39 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. DYAI ranks #367 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in DYAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $790 878
2026-03-31 $145 178
2025-12-31 $167 178
2025-09-30 $210 178
2025-06-30 $176 178
2025-03-31 $240 178
2024-12-31 $311 178
2024-09-30 $185 178
2024-06-30 $263 178
2024-03-31 $560 336
2023-12-31 $535 333
2023-09-30 $623 325
2023-06-30 $622 323
2023-03-31 $561 316
2022-12-31 $385 314
2022-09-30 $593 311
2022-06-30 $761 250
2022-03-31 $733 244
2021-12-31 $1,097 243
2021-09-30 $1,344 242
2021-06-30 $1,084 302
2021-03-31 $113,307 20,639
2020-12-31 $196,471 36,519
2020-09-30 $437,469 57,790
2020-06-30 $315,846 36,472
2020-03-31 $155,375 29,880